A comparison study of the therapeutic effect of " topical steroid" and "honey plus coffee" on Oral Mucositis after chemotherapy and/or radiotherapy.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201104074737N3

Enrollment

Registered

2011-05-09

Start date

2009-03-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K13.7 Other and unspecified lesions of oral mucosa. K13.7

Interventions

Intervention 1: Intervention1 : 500 ml solution containing 20 ampoules that each one contained 8 mg betamethasone" The participants are told to sip 10 cc of the prescribed product, and then swallow it

The participants are told to sip 10 cc of the prescribed product, and then swallow it every 3 hours for one week. Intervention 3: Intervention3: 500 ml solution containing placebo" The participants ar

Treatment - Other

Treatment - Drugs

Placebo

Intervention1 : 500 ml solution containing 20 ampoules that each one contained 8 mg betamethasone" The participants are told to sip 10 cc of the prescribed product, and then swallow it every 3 hours f

Intervention2 : 500 ml solution containing 300gram honey and 20 gram coffee

The participants are told to sip 10 cc of the prescribed product, and then swallow it every 3 hours for one week

Intervention3: 500 ml solution containing placebo" The participants are told to sip 10 cc of the prescribed product, and then swallow it every 3 hours for one week

Eligibility

Sex/Gender

All

Age

15 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Oral Mucositis after chemotherapy and/or radiotherapy /age between 15 and 80 years. Exclusion criteria: Out of this age range - presence of other systemic disease and gastrointestinal disorders.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Oral Mucositis after chemotherapy and/or radiotherapy. Timepoint: Before and after the treatment and also one week after the treatment. Method of measurement: Oral lesions: normal (0), low (+), moderate (++), and severe (+++).	—

Secondary

Measure	Time frame
Pain. Timepoint: Before and after the treatment and also one week after the treatment. Method of measurement: Normal (0), low (+), moderate (++), and severe (+++).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mohammad Ali Raeessi

Baqiyatallah University of Medical Sciences

raeessi_ma@yahoo.com; raeessi@bmsu.ac.ir+98 21 8803 0514

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026